Cargando…
Peripheral blood BRCA1 methylation profiling to predict familial ovarian cancer
OBJECTIVE: Familial cancer appears at a young age and its incidence is increasing. About 12% of familial ovarian cancer cases are associated with BRCA1/2 mutations (BRCAm). In this study, we investigated BRCA1 methylation may predict ovarian cancer in those with a family history of cancer (FHC) but...
Autores principales: | Jung, Yuyeon, Hur, Sooyoung, Liu, JingJing, Lee, Sanha, Kang, Byung Soo, Kim, Myungshin, Choi, Youn Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930454/ https://www.ncbi.nlm.nih.gov/pubmed/33470065 http://dx.doi.org/10.3802/jgo.2021.32.e23 |
Ejemplares similares
-
Plasma Protein Biomarkers Associated with Higher Ovarian Cancer Risk in BRCA1/2 Carriers
por: Ahn, Hee-Sung, et al.
Publicado: (2021) -
Comments on: Peripheral blood BRCA1 methylation profiling to predict familial ovarian cancer
por: Kwon, Janice S.
Publicado: (2021) -
Plasma-derived exosomal miR-4732-5p is a promising noninvasive diagnostic biomarker for epithelial ovarian cancer
por: Liu, Jingjing, et al.
Publicado: (2021) -
Cost-effective BRCA Testing in Advanced Ovarian Cancer
por: Kim, Myungshin
Publicado: (2023) -
Incidence and clinical course of septic shock in neutropenic patients during chemotherapy for gynecological cancers
por: Yoo, Jigeun, et al.
Publicado: (2020)